{"id":4747,"date":"2021-06-27T22:29:38","date_gmt":"2021-06-27T22:29:38","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=4747"},"modified":"2021-06-27T22:29:42","modified_gmt":"2021-06-27T22:29:42","slug":"cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency\/","title":{"rendered":"Cuba&#8217;s Soberana 02 COVID-19 Vaccine To Reach 95% Efficiency"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">The\u00a0clinical trial&#8217;s\u00a0preliminary results show a significant increase in the immune responses of patients between the second and third doses.<\/h1>\n\n\n\n<figure class=\"wp-block-image\"><a href=\"https:\/\/www.telesurenglish.net\/news\/Cubas-Soberana-02-COVID-19-Vaccine-To-Reach-95-Efficiency-20210625-0005.html#\"><img data-recalc-dims=\"1\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/www.telesurenglish.net\/__export\/1624638973214\/sites\/telesur\/img\/2021\/06\/25\/whatsapp_image_2021-06-25_at_12_23_25_pm.jpeg_1718483346.jpeg?w=747&#038;ssl=1\" alt=\"A sample of the Soverign 02 vaccine, Cuba, 2021.\" title=\"A sample of the Soverign 02 vaccine, Cuba, 2021. | Foto: Twitter\/ @cubadebatecu\"\/><\/a><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">On Thursday, Cuba\u2019s Finlay Vaccine Institute announced that its Soberana 02 COVID-19 vaccine is most likely to reach&nbsp;up to&nbsp;95 percent efficiency in third phase of clinical trials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">FVI scientist Maria Toledo explained that that Sovereign 02 research team opted for an application scheme with three doses because the immune response to the vaccine needed to be sustained over time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">She also pointed out that although the clinical trial has not yet concluded, its preliminary results show a significant increase in the immune responses of patients between the second and third doses.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThis yields an immunization schedule efficacy of between 85 and 95 percent\u201d, Toledo said, adding that more experimental data could be available next week.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Besides&nbsp;Soberana 02, Cuba has developed four COVID-19 vaccines: Soberana 01 and Soberana Plus, which were also created by FVI, and Abdala and Mambisa, which were developed by the Center for Genetic Engineering and Biotechnology (CIGB).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">All Cuban vaccines contain &#8220;a protein subunit&#8221; so they produce an immune response through the inoculation of a COVID-19 spike protein. In the IFV vaccines, the antigen was grown in mammalian cells. With the CIGB products, on the other hand, the spike protein was cultivated in yeasts.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cuba\u2019s Center for the Control of Medicines, Equipment and Medical Devices is currently evaluating Abdala prototype to get the official vaccine status. Health authorities&#8217; purpose is to have 70 percent of the population vaccinated in September and 100 percent before the end of the year.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The\u00a0clinical trial&#8217;s\u00a0preliminary results show a significant increase in the immune responses of patients between the second and third doses. On Thursday, Cuba\u2019s Finlay Vaccine Institute<a class=\"moretag\" href=\"https:\/\/www.cubasupport.ie\/latest\/cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":4714,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[43],"tags":[],"class_list":["post-4747","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":3049,"url":"https:\/\/www.cubasupport.ie\/latest\/cuban-vaccine-soberana-02-to-start-phase-clinical-trials\/","url_meta":{"origin":4747,"position":0},"title":"Cuban Vaccine Soberana 02 To Start Phase Clinical Trials","author":"Editorial Team","date":"October 30, 2020","format":false,"excerpt":"Soberana 02 is the second Cuban COVID-19 vaccine candidate to begin clinical trials after being approved by Cuba's\u00a0medical regulatory authorities. The Cuban vaccine candidate against COVID-19, Soberana 02, will start Phase I clinical trials after receiving the approval of the Center for State Control of Drugs, Equipment, and Medical Devices\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana-2.jpeg?fit=800%2C513&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2682,"url":"https:\/\/www.cubasupport.ie\/latest\/how-did-cubas-covid-19-candidate-vaccine-come-to-be-named-soberana\/","url_meta":{"origin":4747,"position":1},"title":"How did Cuba\u2019s COVID-19 candidate vaccine come to be named Soberana?","author":"Editorial Team","date":"September 3, 2020","format":false,"excerpt":"A name identifies, makes unique, and enamors\u2026 It is a calling card and can convey confidence and pride, which is exactly what occurred this month of August, when the people of Cuba heard the long-awaited news that our scientists had come up with an idea, an idea they turned into\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/soberana.jpeg?fit=460%2C340&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":3883,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-to-begin-phase-iii-of-clinical-trials\/","url_meta":{"origin":4747,"position":2},"title":"Cuba&#8217;s Abdala Vaccine to Begin Phase III of Clinical Trials","author":"Editorial Team","date":"March 10, 2021","format":false,"excerpt":"The Center for Genetic Engineering and Biotechnology\u00a0will guarantee\u00a0the doses needed for this clinical trial in which\u00a042,000 people will take\u00a0part. Cuba's President Miguel Diaz-Canel\u00a0on Saturday informed that the Abdala vaccine will start phase III of clinical trials this week in the provinces of Santiago de Cuba and Guantanamo. \"We are one\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":2700,"url":"https:\/\/www.cubasupport.ie\/latest\/media-silence-about-cubas-contributions-against-covid-19-denounced\/","url_meta":{"origin":4747,"position":3},"title":"Media silence about Cuba&#8217;s contributions against Covid-19 denounced","author":"Editorial Team","date":"September 7, 2020","format":false,"excerpt":"Foreign Minister Bruno Rodriguez on Friday denounced the international media silence about Cuba's scientific contributions to the fight against the Covid-19 pandemic.On his Twitter account, the head of Cuban diplomacy noted that, even if men and women of science in the country 'share their achievements with the world, they show\u2026","rel":"","context":"In &quot;Cuba&quot;","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Bruno-twiter.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5590,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-bet-on-home-grown-covid-vaccines-is-paying-off\/","url_meta":{"origin":4747,"position":4},"title":"Cuba\u2019s bet on home-grown COVID vaccines is paying off","author":"Editorial Team","date":"November 30, 2021","format":false,"excerpt":"A health-care worker vaccinates a woman with the Abdala jab in August.Credit: Yamil Lage\/AFP via Getty Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials. When the COVID-19 pandemic began, Cuba decided not to wait on the rest of the world to develop\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/A-health-care-worker-vaccinates-a-woman.jpeg?fit=800%2C532&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5290,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-accelerates-vaccine-drive\/","url_meta":{"origin":4747,"position":5},"title":"Cuba Accelerates Vaccine Drive","author":"Editorial Team","date":"October 5, 2021","format":false,"excerpt":"BY\u00a0HELEN YAFFE \u201cCuba has developed different RBD-based public vaccines, the most administered worldwide (protein-based), and among them the only SARS-CoV-2 conjugate-vaccine (RBD-TT), designed especially for children.\u201d\u2013 Tweet by Fabrizio Chiodo, Italian scientist working with Cuba\u2019s Finlay Institute.[1] Following clinical trials carried out over the summer, on 3 September 2021, Cuba\u2019s\u2026","rel":"","context":"In &quot;Featured&quot;","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/abdela.jpeg?fit=960%2C540&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-1ez","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/4747","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=4747"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/4747\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/4714"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=4747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=4747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=4747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}